Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University of Pittsburgh
7 Hills Pharma, LLC
Incyte Corporation
Incyte Corporation
Children's National Research Institute
Xencor, Inc.
Stanford University
Incyte Corporation
National Cancer Institute (NCI)
Threshold Pharmaceuticals